MedTrace Logo

Clinical Outcomes of Femtosecond Laser Presbyopia Treatment in Monofocal IOLs

NCT07384182 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2026-02-05

No results posted yet for this study

Summary

This study aimed to assess the safety and efficacy of treating presbyopia in eyes implanted with a mono focal IOL using a low-energy femtosecond laser.

Conditions

Interventions

DEVICE

Perfector

The Perfector is used in the procedure. The Device is attached to the patient by the use of a patient attachment. The patient attachment attaches to the sclera of the eye using vacuum pressure.

Sponsors & Collaborators

  • Perfect Lens, LLC

    lead INDUSTRY

Principal Investigators

  • Pavel Stodulka, PhD FEBOS-CR · Gemini Eye Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-15
Primary Completion
2024-11-12
Completion
2024-11-12

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07384182 on ClinicalTrials.gov